Kairos Pharma Appoints Marcum LLP as New Auditor

Ticker: KAPA · Form: 8-K · Filed: Apr 28, 2025 · CIK: 1962011

Kairos Pharma, LTD. 8-K Filing Summary
FieldDetail
CompanyKairos Pharma, LTD. (KAPA)
Form Type8-K
Filed DateApr 28, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: auditor-change, accounting

TL;DR

Kairos Pharma swapped auditors from BDO to Marcum, effective April 23, 2025.

AI Summary

Kairos Pharma, Ltd. announced on April 23, 2025, a change in its certifying accountant. The company has dismissed its previous independent registered public accounting firm, BDO USA, LLP, and has appointed Marcum LLP as its new auditor. This change was approved by the Audit Committee of the Board of Directors.

Why It Matters

A change in auditors can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting, which investors should monitor.

Risk Assessment

Risk Level: low — This filing reports a routine change in the company's auditor, which is a common corporate event and does not inherently indicate financial distress or significant operational changes.

Key Players & Entities

FAQ

When was the change in certifying accountant effective?

The change in certifying accountant was effective as of April 23, 2025.

Who was Kairos Pharma's previous auditor?

Kairos Pharma's previous auditor was BDO USA, LLP.

Who is Kairos Pharma's new auditor?

Kairos Pharma's new auditor is Marcum LLP.

Who approved the change in auditors?

The change in auditors was approved by the Audit Committee of the Board of Directors.

Did the former accountant report any disagreements with Kairos Pharma?

The filing states that there were no disagreements between Kairos Pharma and BDO USA, LLP.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 28, 2025 regarding Kairos Pharma, LTD. (KAPA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing